Skip to main content

Treatment’s Debut AI-driven Health App Getting Five Star Reviews from Doctors

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), is a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions.

Treatment’s landmark debut product, the Treatment Digital Health App, has been garnering five-star reviews on both the Apple App Store and the Google Play Store. Users’ comments have been resoundingly positive about both the comprehensive nature of the assessment, as well as the accuracy of the assessment results. Reviews have come directly from medical doctors in the US, and state that Treatment’s much-anticipated app “is living up to my high expectations; and, equally importantly, does not have the concerns (including inaccuracies and trying to replace physicians) that I had feared. The process of medical data collection (through intelligent questioning with option choices provided) is sound and thorough.”

“The positive feedback our first product has been receiving really speaks to the vision of the team and how it is being brought to life through the app’s intelligent questions, and sound medical information being delivered to end users. I’m pleased that the market is validating the work that went into designing and building the foundational Global Library of Medicine, so that our products can support the medical community in a revolutionary new way, starting with the Treatment Digital Health App,” says CEO and co-founder of Treatment, John Fraser.

The Treatment Digital Health App, revolutionary in the symptom assessment tool marketplace, has been built and is continually updated by a global team of doctors and engineers to provide users with highly predictive and accurate insights about their health. The difference in Treatment’s approach is the foundation of medical information housed in the agile, responsive, AI-driven Global Library of Medicine. By leveraging the industry’s most up-to-date medical information, Treatment products, including the Treatment Digital Health App, provide the most advanced access to medical knowledge ever available for widespread use.

About Treatment.com

Treatment.com is a disruptive healthcare technology company harnessing the power of AI to help global citizens improve their health through personalized recommendations and insights. Based in Vancouver with a US subsidiary, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a sophisticated and scalable AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the company behind the new release of the Treatment Digital Health App. This doctor-built app is driven by an intelligent digital health assistant which will empower people to take control of their health. Doctors are encouraged to apply for NFT and blockchain rewards for contributing to Treatment’s growing compendium of medical knowledge housed in its proprietary Global Library of Medicine.

For more investor information on Treatment.com please visit https://treatment.com/investors/.

Release issued by: John Fraser, CEO

Main Line: +1 (612) 788-8900
Toll Free USA/Canada: +1 (888) 788-8955

Forward Looking Statement

This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment’s expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

For more information:

Investor Contact: investors@treatment.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.